Chemoprevention of cancer for the next millennium--quo vadis?
Zänker
K S
KS
Institute of Immunology, University Witten/Herdecke, Germany.
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D018450:Disease Progression; D004311:Double-Blind Method; D005419:Flavonoids / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment
D016588:Anticarcinogenic Agents; D015415:Biomarkers; D005419:Flavonoids